EUVIMEDEUVIMED entdecken
Open Access · CC BY-ND 4.0

Features of the Persistence of IgG Antibodies Against SARS-­CoV-­2 in People Living with HIV

A.Yu. Mazurenko, K.Yu. Lytvyn

Tuberculosis, Lung Diseases, HIV Infection · 06.11.2026 · (4) · 27-32

DOI: 10.30978/tb2026-4-27 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tuberculosis, Lung Diseases, HIV Infection, online erschienen am 06.11.2026. Verfasst von A.Yu. Mazurenko und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective — to analyse the peculiarities of the persistence of specific IgG antibodies to the S-protein of SARS-CoV-2 in people living with HIV (PLHIV) to improve the strategy of specific prevention of coronavirus disease in this group. Materials and methods. A total of 129 individuals were examined: the main group — 80 PLHIV (mean age — (44.8 ± 9.7) years, 96.3 % received ART), the comparison group — 49 HIV-negative individuals (mean age — (43.5 ± 13.3) years). Clinical-anamnestic, immunological (flow cytometry of CD4+), molecular-biological (PCR) and serological methods (quantification of IgG to the S-protein by the Vitrotest® SARS-CoV-2 IgG QuantiSpike test system) were used. Statistical processing was carried out using the STATISTICA v.6.1 package. Results and discussion. The optical density (OD) of the blood serum sample in the quantitative determination of IgG antibodies to the S-protein of SARS-CoV-2 in PLHIV was found to be significantly lower than in non-HIV individuals (2.23 ± 1.10 and 2.87 ± 0.94, respectively; p = 0.001). A high level of OD (≥ 3.0) was recorded in only 43.8 % of PLHIV versus 67.3 % in the comparison group (p = 0.009). Analysis of influencing factors showed that the formation of a humoral response in PLHIV is influenced by vaccination status and disease history. A direct correlation was found between IgG level and vaccination (rv = 0.317, p = 0.046), and the number of vaccinations (rs = 0.305, p = 0.006). Of the patients who received two or more doses, 82.4 % had higher antibody levels. IgG persistence was influenced by having had the disease during the last two years (rv = 0.363, p = 0.005). Conclusions. Individuals in the main group had a significantly lower frequency of higher IgG titres (OD ≥ 3.0) — 43.8 % than 67.3 % in the comparison group (p = 0.009), which demonstrates the specificity of the immunological profile depending on the study group. A high level of antibody persistence in PLHIV was associated with vaccination (rv = 0.317, p = 0.046), the number of vaccinations against coronavirus disease 2019 (rs = 0.305, p = 0.006), as well as with having had the disease (rv = 0.328, p = 0.035), especially within two years before the study (rv = 0.363, p = 0.005). The level of IgG antibodies to the S-protein of SARS-CoV-2 in PLHIV depends on vaccination status and previous infection, which requires a special approach to the prevention of coronavirus disease in this group.

Zitieren

APA

Mazurenko, A., & Lytvyn, K. (2026). Features of the Persistence of IgG Antibodies Against SARS-­CoV-­2 in People Living with HIV. Tuberculosis, Lung Diseases, HIV Infection, 27-32. https://doi.org/10.30978/tb2026-4-27

Vancouver

Mazurenko A, Lytvyn K. Features of the Persistence of IgG Antibodies Against SARS-­CoV-­2 in People Living with HIV. Tuberculosis, Lung Diseases, HIV Infection. 2026:27-32. doi:10.30978/tb2026-4-27

BibTeX
@article{Mazurenko2026,
  author = {Mazurenko, A.Yu. and Lytvyn, K.Yu.},
  title = {Features of the Persistence of IgG Antibodies Against SARS-­CoV-­2 in People Living with HIV},
  journal = {Tuberculosis, Lung Diseases, HIV Infection},
  year = {2026},
  number = {4},
  pages = {27--32},
  doi = {10.30978/tb2026-4-27}
}
Kostenlos starten →